It's time to re-evaluate cervical Cancer screening after age 65


      • Cervical cancer screening guidelines recommend screening stop after age 65 despite 20% of new cases occurring in this group
      • Demographics, research methods and treatment paradigms are changing and guidelines may not adequately address these changes
      • Racial disparities in cervical cancer may be exacerbated by not addressing the preventive health needs of older women


      Cervical cancer screening guidelines currently recommend cessation of cervical cancer screening after age 65, despite 20% of new cervical cancer cases occurring in this age group. The US population is aging, research methodology that examines cervical cancer incidence and mortality rates has changed, and sexual behaviors and the rates at which women have hysterectomies have changed over time. Current guidelines do not adequately address these changes, and may be missing significant opportunities to prevent cervical cancer cases and deaths in older women. Furthermore, racial disparities in cervical cancer outcomes may be exacerbated by not addressing the preventive health needs of older women through cervical cancer screening.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Surgeons ACo
        National Cancer Database.
        (Accessed August 19, 2018)
        • Institute NC
        SEER Data.
        (Accessed August 19, 2018)
        • Dilley S.E.
        • O’Donnell J.A.
        • Smith H.J.
        • Bae S.
        • Huh W.
        Rethinking cervical cancer screening guidelines in an aging U.S. population.
        Gynecol. Oncol. 2018; 149: 28
        • Fox K.V.
        • Shah C.A.
        • Swisher E.M.
        • et al.
        An evaluation of cervical cancer in women age sixty and over.
        Gynecol. Oncol. 2008; 109: 53-58
        • Massad L.S.
        • Einstein M.H.
        • Huh W.K.
        • et al.
        2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
        Obstet. Gynecol. 2013; 121: 829-846
        • Rositch A.F.
        • Nowak R.G.
        • Gravitt P.E.
        Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
        Cancer. 2014; 120: 2032-2038
        • Beavis A.L.
        • Gravitt P.E.
        • Rositch A.F.
        Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
        Cancer. 2017; 123: 1044-1049
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2020.
        CA Cancer J. Clin. 2020; 70: 7-30
        • Yoo W.
        • Kim S.
        • Huh W.K.
        • et al.
        Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
        PLoS One. 2017; 12e0172548
        • Fontham E.T.H.
        • Wolf A.M.D.
        • Church T.R.
        • et al.
        Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
        CA Cancer J. Clin. 2020; 70: 321-346
        • Force U.P.S.T.
        Screening for cervical Cancer: US preventive services task Force recommendation statement.
        JAMA. 2018; 320: 674-686
        • Kulasingam S.L.
        • Havrilesky L.
        • Ghebre R.
        • Myers E.R.
        Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
        Agency for Healthcare Research and Quality (US), Rockville (MD)2011
        • Gravitt P.E.
        • Landy R.
        • Schiffman M.
        How confident can we be in the current guidelines for exiting cervical screening?.
        Prev. Med. 2018; 114: 188-192
        • Dinkelspiel H.
        • Fetterman B.
        • Poitras N.
        • et al.
        Screening history preceding a diagnosis of cervical cancer in women age 65 and older.
        Gynecol. Oncol. 2012; 126: 203-206
        • Hammer A.
        • Soegaard V.
        • Maimburg R.D.
        • Blaakaer J.
        Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-a national cohort study.
        Cancer Med. 2019; 8: 418-427
        • Castanon A.
        • Landy R.
        • Cuzick J.
        • Sasieni P.
        Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
        PLoS Med. 2014; 11e1001585
        • Yost S.
        • Hoekstra A.
        Cervical cancer in women over 65: an analysis of screening.
        Gynecol. Oncol. Rep. 2018; 25: 48-51
        • Loopik D.L.
        • IntHout J.
        • Ebisch R.M.F.
        • et al.
        The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women.
        Gynecol. Oncol. 2020; 157: 195-201
      1. Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States. In: U.S. Department of Commerce EaSA, U.S. Census Bureau ed2014.

        • Rodríguez A.C.
        • Schiffman M.
        • Herrero R.
        • et al.
        Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
        J. Natl. Cancer Inst. 2010; 102: 315-324
        • Paul P.
        • Hammer A.
        • Rositch A.F.
        • et al.
        Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior.
        J. Infect. Dis. 2020; jiaa557
        • Rositch A.F.
        • Burke A.E.
        • Viscidi R.P.
        • Silver M.I.
        • Chang K.
        • Gravitt P.E.
        Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.
        Cancer Res. 2012; 72: 6183
        • Winer R.L.
        • Hughes J.P.
        • Feng Q.
        • Stern J.E.
        • Xi L.F.
        • Koutsky L.A.
        Incident detection of high-risk human papillomavirus infections in a cohort of high-risk women aged 25–65 years.
        J. Infect. Dis. 2016; 214: 665-675
        • Gravitt P.E.
        • Rositch A.F.
        • Silver M.I.
        • et al.
        A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.
        J. Infect. Dis. 2013; 207: 272-280
        • National Center for Health S. Health, United States
        Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities.
        National Center for Health Statistics (US), Hyattsville (MD)2016
        • Doll K.M.
        • Winn A.N.
        Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
        Am. J. Obstet. Gynecol. 2019; 221: 318.e311-318.e319
        • Simms K.T.
        • Yuill S.
        • Killen J.
        • et al.
        Historical and projected hysterectomy rates in the USA: implications for future observed cervical cancer rates and evaluating prevention interventions.
        Gynecol. Oncol. 2020; 158: 710-718
        • Wright J.D.
        • Herzog T.J.
        • Tsui J.
        • et al.
        Nationwide trends in the performance of inpatient hysterectomy in the United States.
        Obstet. Gynecol. 2013; 122: 233-241
        • Hammer A.
        • Kahlert J.
        • Gravitt P.E.
        • Rositch A.F.
        Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: a registry-based cohort study.
        Acta Obstet. Gynecol. Scand. 2019; 98: 1063-1069
        • Castle P.E.
        • Fetterman B.
        • Thomas Cox J.
        • et al.
        The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
        Obstet. Gynecol. 2010; 116: 76-84
        • Tranberg M.
        • Bech B.H.
        • Blaakær J.
        • Jensen J.S.
        • Svanholm H.
        • Andersen B.
        Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
        BMC Cancer. 2018; 18: 273